Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Checkpoint Therapeutics Inc (CKPT)
NASDAQ:CKPT
RESEARCH TOOLSreports
Holding CKPT?
Track your performance easily
CKPT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.36 - $3.97
Previous Close$3.46
Volume432.63K
Average Volume (3M)601.76K
Market Cap
$151.71M
Enterprise Value$150.81M
Total Cash (Recent Filing)$4.95M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.43
Next Earnings
Mar 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.50
Shares Outstanding45,017,841
10 Day Avg. Volume1,303,316
30 Day Avg. Volume601,760
Standard Deviation0.21
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-9.89
Price to Sales (P/S)1945.00
Price to Cash Flow (P/CF)-6.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.46K
Enterprise Value/Gross Profit1.46K
Enterprise Value/Ebitda-3.60
Forecast
1Y Price Target
$12.00Price Target Upside246.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Checkpoint Therapeutics News
Ownership Overview
15.85% Insiders
3.78% Mutual Funds
0.80% Other Institutional Investors
76.34% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CKPT FAQ
What was Checkpoint Therapeutics Inc’s price range in the past 12 months?
Checkpoint Therapeutics Inc lowest stock price was $1.36 and its highest was $3.97 in the past 12 months.
What is Checkpoint Therapeutics Inc’s market cap?
Currently, no data Available
When is Checkpoint Therapeutics Inc’s upcoming earnings report date?
Checkpoint Therapeutics Inc’s upcoming earnings report date is Mar 13, 2025 which is in 125 days.
How were Checkpoint Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Checkpoint Therapeutics Inc overvalued?
According to Wall Street analysts Checkpoint Therapeutics Inc’s price is currently Undervalued.
Does Checkpoint Therapeutics Inc pay dividends?
Checkpoint Therapeutics Inc does not currently pay dividends.
What is Checkpoint Therapeutics Inc’s EPS estimate?
Checkpoint Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Checkpoint Therapeutics Inc have?
Checkpoint Therapeutics Inc has 44,317,840 shares outstanding.
What happened to Checkpoint Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Checkpoint Therapeutics Inc?
Currently, no hedge funds are holding shares in CKPT
---
Checkpoint Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (246.82% Upside)
$12.00 (246.82% Upside)
Blogger Sentiment
Bullish
CKPT Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Negative
Last 7 Days >0.1%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
73.86%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-32.00%
Trailing 12-Months
Company Description
Checkpoint Therapeutics Inc
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.
---
CKPT Stock 12 Month Forecast
Average Price Target
$12.00
▲(246.82% Upside)
Technical Analysis
Karyopharm Therapeutics
―
Oncternal Therapeutics
―
Fennec Pharmaceuticals
―
Molecular Templates
―
Best Analysts Covering CKPT
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+20.53%
reiterated a buy rating 3 months ago
Copying Thomas Flaten's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +20.53% per trade.
---